Biomaterial Database

[Serum complement value in scarlet fever]. 1977

I Takase, and Y Takizawa, and I Tomizawa, and Y Akiwa

UI	MeSH Term	Description	Entries
D002648	Child	A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL.	Children
D002675	Child, Preschool	A child between the ages of 2 and 5.	Children, Preschool,Preschool Child,Preschool Children
D003165	Complement System Proteins	Serum glycoproteins participating in the host defense mechanism of COMPLEMENT ACTIVATION that creates the COMPLEMENT MEMBRANE ATTACK COMPLEX. Included are glycoproteins in the various pathways of complement activation (CLASSICAL COMPLEMENT PATHWAY; ALTERNATIVE COMPLEMENT PATHWAY; and LECTIN COMPLEMENT PATHWAY).	Complement Proteins,Complement,Complement Protein,Hemolytic Complement,Complement, Hemolytic,Protein, Complement,Proteins, Complement,Proteins, Complement System
D003176	Complement C3	A glycoprotein that is central in both the classical and the alternative pathway of COMPLEMENT ACTIVATION. C3 can be cleaved into COMPLEMENT C3A and COMPLEMENT C3B, spontaneously at low level or by C3 CONVERTASE at high level. The smaller fragment C3a is an ANAPHYLATOXIN and mediator of local inflammatory process. The larger fragment C3b binds with C3 convertase to form C5 convertase.	C3 Complement,C3 Precursor,Complement 3,Complement C3 Precursor,Complement Component 3,Precursor-Complement 3,Pro-C3,Pro-Complement 3,C3 Precursor, Complement,C3, Complement,Complement, C3,Component 3, Complement,Precursor Complement 3,Precursor, C3,Precursor, Complement C3,Pro C3,Pro Complement 3
D003181	Complement C4	A glycoprotein that is important in the activation of CLASSICAL COMPLEMENT PATHWAY. C4 is cleaved by the activated COMPLEMENT C1S into COMPLEMENT C4A and COMPLEMENT C4B.	C4 Complement,C4 Complement Component,Complement 4,Complement C4, Precursor,Complement Component 4,Pro-C4,Pro-complement 4,C4, Complement,Complement Component, C4,Complement, C4,Component 4, Complement,Component, C4 Complement,Pro C4,Pro complement 4
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293	Adolescent	A person 13 to 18 years of age.	Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D012541	Scarlet Fever	Infection with group A streptococci that is characterized by tonsillitis and pharyngitis. An erythematous rash is commonly present.	Fever, Scarlet,Fevers, Scarlet,Scarlet Fevers

Related Publications

I Takase, and Y Takizawa, and I Tomizawa, and Y Akiwa

COMPLEMENT FIXATION IN SCARLET FEVER WITH IMMUNE SERA.

December 1930, Canadian Medical Association journal,

I Takase, and Y Takizawa, and I Tomizawa, and Y Akiwa

[Etiology of scarlet fever and the virucidal effect of convalescent scarlet fever serum].

August 1951, Zentralblatt fur Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene. 1. Abt. Medizinisch-hygienische Bakteriologie, Virusforschung und Parasitologie. Originale,

I Takase, and Y Takizawa, and I Tomizawa, and Y Akiwa

Chemotherapy or Serum for Scarlet Fever?

November 1943, British medical journal,

I Takase, and Y Takizawa, and I Tomizawa, and Y Akiwa

[BLOOD SERUM PROTEIN FRACTIONS IN SCARLET FEVER].

April 1963, Zdravookhranenie Belorussii,

I Takase, and Y Takizawa, and I Tomizawa, and Y Akiwa

THE USE OF SERUM IN SCARLET FEVER.

May 1908, British medical journal,

I Takase, and Y Takizawa, and I Tomizawa, and Y Akiwa

The Prophylactic Value of Scarlet Fever Antitoxin.

January 1926, British medical journal,